SurgePays (SURG) Common Equity (2010 - 2026)

SurgePays has disclosed Common Equity across 17 years of filings, most recently posting -$23.9 million for Q1 2026.

• In Q1 2026, Common Equity fell 406.73% year-over-year to -$23.9 million; the TTM figure through Mar 2026 stood at -$23.9 million (down 406.73% YoY), while the FY2025 annual figure was -$15.3 million, down 200.56% from the prior year.
• Common Equity declined to -$23.9 million in Q1 2026, from -$15.3 million in the prior quarter.
• Over the last five years, Common Equity for SURG reached as high as $56.2 million in Q1 2024 and fell as low as -$23.9 million in Q1 2026.
• The 5-year median for Common Equity is $7.8 million (2025), against an average of $11.9 million.
• Annual changes were most pronounced in 2023 — Common Equity soared 5037.73% — and 2026, when it slumped 406.73%.
• A 5-year view of Common Equity shows it stood at $5.1 million in 2022, then soared by 454.94% to $28.4 million in 2023, then slumped by 46.27% to $15.3 million in 2024, then sank by 200.56% to -$15.3 million in 2025, then sank by 55.52% to -$23.9 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered -$23.9 million, -$15.3 million, and -$6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.